Evidence map›Paper›PMID 32568661›Full record

ArticleEmerging infectious diseases2020

Persistence of Severe Acute Respiratory Syndrome Coronavirus 2 in Aerosol Suspensions.

Alyssa C Fears, William B Klimstra, Paul Duprex, Amy Hartman, Scott C Weaver, Kenneth S Plante, Divya Mirchandani, Jessica Ann Plante, Patricia V Aguilar, Diana Fernández and 10 more

Open access · diamondAbstract read
In one paragraph

Article in Emerging infectious diseases, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 172 papers, 7 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
172citing papers in PubMed, 7 pooled it
36.5field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

172 citing papers in PubMed, 7 syntheses or guidelines pooled it, 332 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. SARS-CoV-2: a systematic review of indoor air sampling for virus detection.Environmental science and pollution research international · 2021
    Pooled it
  6. Airborne transmission of SARS-CoV-2 via aerosols.Reviews in medical virology · 2021
    Pooled it
  7. Pooled it
  8. Article
  9. Article
  10. Article
  11. Article
  12. Risk assessment of infection of COVID-19 contacts based on scenario simulation.Risk analysis : an official publication of the Society for Risk Analysis · 2025
    Article
  13. Article
  14. Review
  15. Article
  16. Air Change Rate and SARS-CoV-2 Exposure in Hospitals and Residences: A Meta-Analysis.Aerosol science and technology : the journal of the American Association for Aerosol Research · 2024
    Article
  17. Article
  18. Review
  19. Understanding lifetime and dispersion of cough-emitted droplets in air.Indoor + built environment : the journal of the International Society of the Built Environment · 2023
    Article
  20. Aerobiology · 2023
    Article

112 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

20 authors at 6 institutions in 1 country.

Alyssa C Fears
William B Klimstra
Paul Duprex
Amy Hartman
Scott C Weaver
Kenneth S Plante
Divya Mirchandani
Jessica Ann Plante
Patricia V Aguilar
Diana Fernández
Aysegul Nalca
Aysegul Totura
David Dyer
Brian Kearney
Matthew Lackemeyer
J Kyle Bohannon
Reed Johnson
Robert F Garry
Doug S Reed
Chad J Roy
University of Pittsburgh · USNational Institutes of Health · USThe University of Texas Medical Branch at Galveston · USNational Institute of Allergy and Infectious Diseases · USUnited States Army Medical Research Institute of Infectious Diseases · USTulane University · US

Funding

Tulane NPRC SPF Sheltered Outdoor Enclosure ExpansionP51OD011104 · OD · TULANE UNIVERSITY OF LOUISIANA · PI L Lee HAMM · 2012 to 2026
$142.4M
Technology CoreU19AI135995 · NIAID · SCRIPPS RESEARCH INSTITUTE, THE · PI Laura D. Hughes · 2018 to 2026
$32.0M
World Reference Center for Emerging Viruses and Arboviruses (WRCEVA)R24AI120942 · NIAID · UNIVERSITY OF TEXAS MED BR GALVESTON · PI WEAVER, SCOTT C · 2016 to 2024
$8.5M
Research Training Program on the Impact of Zoonotic and Vector-borne Viruses, Rickettsiae, and Leptospira in Acute Undifferentiated Febrile IllnessesD43TW010331 · FIC · UNIVERSITY OF TEXAS MED BR GALVESTON · PI AGUILAR, PATRICIA VERONICA, RODAS, JUAN DAVID · 2016 to 2025
$2.6M
NIAID NIH HHS HHSN272200700016INIAID NIH HHS HHSN272201800013CNIAID NIH HHS R24 AI120942NIAID NIH HHS U19 AI135995NIH HHS P51 OD011104
6 · The paper itself

Abstract

We aerosolized severe acute respiratory syndrome coronavirus 2 and determined that its dynamic aerosol efficiency surpassed those of severe acute respiratory syndrome coronavirus and Middle East respiratory syndrome. Although we performed experiment only once across several laboratories, our findings suggest retained infectivity and virion integrity for up to 16 hours in respirable-sized aerosols.

Indexed as

Disease Transmission, InfectiousAerosolsBetacoronavirusCoronavirus InfectionsCOVID-19HumansMiddle East Respiratory Syndrome CoronavirusPandemicsPneumonia, ViralSARS-CoV-2SuspensionsAerosolsSuspensions2019 novel coronavirus diseaseaerosolcoronavirus diseasesCOVID-19MERS-CoVMiddle East respiratory syndrome coronavirusrespiratory diseasesSARS-CoVSARS-CoV-2severe acute respiratory syndrome coronavirussevere acute respiratory syndrome coronavirus 2viruseszoonoses

Identifiers

PMID32568661
PMCPMC7454081
OpenAlexW3036295571

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.